A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF)
A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF)
Active, not recruiting · NCT03773393 · Registry updated 2025-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF) | Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder | Active, not recruiting | Phase 1 | 2025-04-13 | NCT03773393 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cellenkos, Inc. | 5 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sarcoma Oncology Research Center, Cancer Center of Southern California | Santa Monica | United States | 1 |
| The University of Texas MD Anderson Cancer Center | Houston | United States | 207 |